5-MeS-DMT
| Clinical data | |
|---|---|
| Other names | 5-Methylthio-N,N-dimethyltryptamine; 5-Methylthio-DMT |
| Routes of administration | Smoking[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | Very fast[1] |
| Duration of action | 10–30 minutes or <1 hour[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H18N2S |
| Molar mass | 234.36 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
5-MeS-DMT, also known as 5-methylthio-N,N-dimethyltryptamine or as 5-methylthio-DMT, is a lesser-known psychedelic drug of the tryptamine family.[1] It is the 5-methylthio derivative of dimethyltryptamine (DMT) and is an analogue of 5-MeO-DMT.[1]
Use and effects
[edit]In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose as 15 to 30 mg smoked and its duration as less than 1 hour.[1] In individual reports, the duration was 10 to 30 minutes.[1] The effects included feeling stoned and no visuals, among others.[1] It was also described as coming on very fast and being quite intense.[1] The drug is described as being about half as potent as 5-MeO-DMT.[1]
Interactions
[edit]Pharmacology
[edit]Pharmacodynamics
[edit]5-MeS-DMT was less potent than 5-MeO-DMT and psilocin (4-HO-DMT) but more potent than 4-MeO-DMT or 4-MeS-DMT in rodent behavioral studies.[2][3][4]
Chemistry
[edit]Synthesis
[edit]The chemical synthesis of 5-MeS-DMT has been described.[1]
Analogues
[edit]Analogues of 5-MeS-DMT include dimethyltryptamine (DMT), 5-MeO-DMT, and 5,N,N-TMT (5-methyl-DMT; 5-Me-DMT), among others.[1]
History
[edit]It was first described in the scientific literature by Richard Glennon and colleagues by 1982.[2][3][4] However, 5-MeS-DMT was synthesized and tested by Shulgin as early as 1979.[5]
See also
[edit]References
[edit]- ^ a b c d e f g h i j k l Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252. "#46. 5-MES-DMT".
- ^ a b Glennon RA, Young R, Benington F, Morin RD (February 1982). "Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and 5-OMe DMT with their methythio counterparts". Life Sciences. 30 (5): 465–467. doi:10.1016/0024-3205(82)90463-5. PMID 6801410.
- ^ a b Kline TB, Benington F, Morin RD, Beaton JM (August 1982). "Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety". Journal of Medicinal Chemistry. 25 (8): 908–913. doi:10.1021/jm00350a005. PMID 7120280.
- ^ a b Kline TB, Benington F, Morin RD, Beaton JM, Glennon RA, Domelsmith LN, et al. (November 1982). "Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives". Journal of Medicinal Chemistry. 25 (11): 1381–1383. doi:10.1021/jm00353a021. PMID 6815326.
- ^ Shulgin A. "PhiKAL Notebook" (PDF). isomer design.